Skip to main content
. Author manuscript; available in PMC: 2024 Jan 18.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2023 Jan 18;37(1):20–27. doi: 10.1097/WAD.0000000000000538

TABLE 2.

Baseline demographic characteristics by any anticholinergic drug use

All (n=1955) any anticholinergic drug: no (n=596) any anticholinergic drug: yes (n=1359) P value
Age 77.6 (7.4) 77.1 (7.3) 77.8 (7.4) 0.059*

Female 1198 (61.3%) 360 (60.4%) 838 (61.7%) 0.634**

Education 0.090**
 < high school 264 (13.5%) 78 (13.1%) 186 (13.7%)
 = high school 883 (45.2%) 250 (41.9%) 633 (46.6%)
 > high school 808 (41.3%) 268 (45.0%) 540 (39.7%)

Total number of prescription medications 4 [2; 6] 1 [0; 3] 5 [3; 7] <0.001***

Table shows mean (SD), or frequency (%), or median [Q1; Q3]. P values reflect tests for significant differences between any anticholinergic drug use groups using the following tests:

*

t test;

**

Chi-squared test;

***

Wilcoxon-Mann-Whitney test.